{"entity":{"id":"intra-immusg","kind":"company","name":"Intra-IMMUSG","aka":["Intra-IMMUSG Pte Ltd"],"tldr":"Intra-IMMUSG is a Singapore-based biotechnology company running 3 late-stage cancer trials.","summary":"Intra-IMMUSG, based in Singapore, Singapore, is a biotechnology company. Intra-ImmuSG is a Phase 2 clinical-stage biotechnology company developing antibody-based cancer immunotherapies that target intracellular tumour antigens exposed on the cancer cell surface. On ClinicalTrials.gov it is the lead sponsor of 3 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3). The largest, NCT07541001 (PRL3-Zumab in Patients With Advanced Solid Tumours), plans to enrol 60 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.intra-immusg.com"},{"label":"ClinicalTrials.gov: trials led by Intra-IMMUSG","url":"https://clinicaltrials.gov/search?lead=Intra-IMMUSG%20Pte%20Ltd"}],"tags":["ctgov-sponsor"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["pivotal-trial","clinical-trial"],"trials":["nct07290088","nct07541001","nct04452955"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Singapore","country":"SG","companyType":"biotech","website":"https://www.intra-immusg.com","stage":"growth","investors":[],"funding":[]},"route":"/companies/intra-immusg/","neighbours":{"term":[{"id":"clinical-trial","kind":"term","name":"Clinical trial","route":"/terms/clinical-trial/"},{"id":"pivotal-trial","kind":"term","name":"Pivotal (registrational) trial","route":"/terms/pivotal-trial/"}],"trial":[{"id":"nct04452955","kind":"trial","name":"A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors","route":"/trials/nct04452955/"},{"id":"nct07290088","kind":"trial","name":"Phase II/III Trial of PRL3-Zumab in Advanced Solid Tumor Patients","route":"/trials/nct07290088/"},{"id":"nct07541001","kind":"trial","name":"PRL3-Zumab in Patients With Advanced Solid Tumors","route":"/trials/nct07541001/"}]}}